Aclarion (ACON) Stock: Buy, Sell, or Hold?
ACON - Aclarion, Inc. Common Stock
$2.60
0.06 (2.36%)
â˛
5d:
+13.54%
30d:
+12.07%
90d:
-19.0%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Aug 13, 2026
0d
Get Alerted When ACON Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: ACON is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: ACON is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: ACON is currently trading at $2.60, which is considered slightly high relative to its 30-day fair value range of $2.31 to $2.61.
Technical Outlook: Technically, ACON is in a strong downtrend. The price is approaching resistance at $2.64. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $7.50 (+188.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ACON is in a strong downtrend. The price is approaching resistance at $2.64. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $7.50 (+188.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$2.31 -
$2.61
Company Quality Score
38/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
66.8%
All Signals
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 188.5% below Wall St target ($7.50)
- WARNING: Composite score 38/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$2.31 -
$2.61
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$2.25
Resistance Level
$2.64
Current Trend
Strong Downtrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.48
Wall Street Target
$7.50
(+188.5%)
Revenue Growth (YoY)
30.5%
Share & Embed Analysis
Last updated: September 12, 2026 5:03 AM ET
Data refreshes hourly during market hours. Next update: 6:03 AM
Data refreshes hourly during market hours. Next update: 6:03 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ACON showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VEEV
Veeva Systems Inc Class A |
BUY
32 analysts |
$294 | 39 SELL |
|
PRVA
Privia Health Group Inc |
STRONG BUY
21 analysts |
$32 | 42 HOLD |
|
GEHC
GE HealthCare TechnologiâĻ |
STRONG BUY
21 analysts |
$90 | 49 HOLD |
|
PHR
Phreesia Inc |
STRONG BUY
15 analysts |
$14 | 51 HOLD |
|
WAY
Waystar Holding Corp. CoâĻ |
STRONG BUY
13 analysts |
$33 | 45 HOLD |
